CLINICAL_TRIALS ClinicalTrials.gov record update

a New Spark in Treating Oligorecurrent Prostate Cancer: Adding Systemic Treatment to Stereotactic Body Radiotherapy or Metastasectomy: Key to Long-lasting Event-free Survival?

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT05352178
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:26:23.811334+00:00
Published At: 2024-07-03T00:00:00+00:00
Record Updated At: 2024-07-03
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Prostate Cancer", "Prostate Cancer Recurrent", "Prostate Cancer Metastatic", "Metastatic Cancer", "Oligometastatic Disease", "Oligometastasis", "Hormone Sensitive Prostate Cancer"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2024-07-03"
protocolSection.identificationModule.nctId: "NCT05352178"
protocolSection.identificationModule.officialTitle: "a New Spark in Treating Oligorecurrent Prostate Cancer: Adding Systemic Treatment to Stereotactic Body Radiotherapy or Metastasectomy: Key to Long-lasting Event-free Survival?"
protocolSection.statusModule.overallStatus: "RECRUITING"
protocolSection.designModule.phases: ["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.